Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Lowering blood pressure in black African patients

Dual therapies combining a calcium-channel blocker with an angiotensin-converting enzyme (ACE) inhibitor or thiazide diuretic are more effective at lowering blood pressure in black African patients than the combination of an ACE inhibitor and a thiazide diuretic, according to results presented at ACC.19.

Credit: V. Summersby/Springer Nature Limited

Dual therapies are needed in many patients to control blood pressure effectively; however, recommendations for combination therapies in black patients differ across three guidelines in the USA and the latest European guidelines. “We decided to do this research because before now no large randomized controlled trials have compared the efficacy of contemporary combination therapies among any black populations, in spite of the high burden of hypertension and its complications in this population,” explains Dike Ojji, corresponding author.

In this trial, 728 black patients with uncontrolled hypertension from six countries in sub-Saharan Africa were randomly assigned to receive amlodipine (a calcium-channel blocker) and hydrochlorothiazide (a thiazide diuretic), amlodipine and perindopril (an ACE inhibitor) or perindopril and hydrochlorothiazide. The primary end point was change in 24-h ambulatory systolic blood pressure between baseline and 6 months.

Patients who received either of the combinations containing amlodipine had a larger reduction in blood pressure than those patients who received perindopril and hydrochlorothiazide. The efficacy of calcium-channel blockers as monotherapy in black patients is well established, and the results from this study suggest that a calcium-channel blocker might also be the vital component in dual therapies.

“A calcium-channel blocker might also be the vital component in dual therapies”

“This study emphasizes the need to establish optimal antihypertensive combination therapies by ethnicity,” says Ojji. “It would also be interesting to carry out the same project in African Americans and compare results as it is difficult to extrapolate our work to this population because of gene–environment interaction and genetic admixture.”


Original article

  1. Ojji, D. B. et al. Comparison of dual therapies for lowering blood pressure in Black Africans. N. Engl. J. Med. (2019)

    Article  PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Isobel Leake.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leake, I. Lowering blood pressure in black African patients. Nat Rev Cardiol 16, 323 (2019).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing